New York-based pharma giant Pfizer will finally be able to complete its $43 billion acquisition of Seagen, having addressed all of the concerns of antitrust reg 13 December 2023
Continuing a busy period of dealmaking, pharma major AstraZeneca has confirmed it will buy vaccine specialist Icosavax for around $800 million. 12 December 2023
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
British cell and gene therapy firm Oxford Biomedica has agreed terms with a subsidiary of Institut Mérieux for the acquisition of ABL Europe, for around $16 mil 4 December 2023
Another month has passed into the annals of history, but not without note, so far as the pharmaceutical M&A world is concerned, thanks to the announcement of a 1 December 2023
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.